Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in DMD with Cardiac Dysfunction (DELPHI)
NCT00654784Phase 2Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Oct 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idebenone in Duchenne muscular dystrophy (DMD), sponsored by Santhera Pharmaceuticals. Started Oct 2005; status: completed.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT00654784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654784.